NU670 Unit 9 Study Critique, Santarelli 2003 Example

Irradiated Mice and a Popular Claim: A Study Critique of Santarelli and Colleagues (2003) on Hippocampal Neurogenesis and Antidepressant Action

[Student Name]

Purdue University Global

NU670: PMHNP Neuroscience and Psychopharmacology

Unit 9 Study Critique

[Instructor Name]

[Date]

The critique concerns a published study; no patient data are involved.

The Study and Its Question

By the early 2000s, several groups had shown that chronic antidepressant treatment increases the birth of new neurons in the dentate gyrus of the adult rodent hippocampus. The open question was whether this neurogenesis was necessary for the drugs' behavioral effects or simply a side effect. Santarelli and colleagues set out to answer it by removing neurogenesis and seeing whether the drugs still worked (Santarelli et al., 2003).

They used two approaches. First, they studied mice lacking the serotonin 1A receptor and found that these mice showed neither the increase in neurogenesis nor the behavioral response to fluoxetine. Second, they used focused X-irradiation of a restricted region of the mouse brain containing the hippocampus, which stopped the production of new neurons, and found that the neurogenic and behavioral effects of two classes of antidepressants, fluoxetine and the tricyclic imipramine, were prevented. They concluded that the behavioral effects of chronic antidepressants "may be mediated" by stimulation of hippocampal neurogenesis (Santarelli et al., 2003).

What the Design Does Well

The design is a strong one for the question the authors asked. Rather than showing only that antidepressants and neurogenesis occur together, it removes neurogenesis and tests whether the drug effect disappears, an approach that can support a claim of necessity. Two independent methods, a genetic knockout and a physical ablation, point in the same direction, and two different drug classes were tested. Irradiation was restricted to a region, not the whole brain, which reduced the chance that the effect came from damage elsewhere. The paper was published in a leading journal after peer review, and it opened a productive line of research.

Limits Within the Study

Four limits keep the conclusion narrower than it first appears.

1. The behavioral tests. The antidepressant effect was measured with tests of anxiety-like and stress-related behavior in mice, notably the latency to eat in a novel environment. These tests respond to chronic antidepressants, which is why they were chosen, but they are models of particular behaviors, not of human depression with its low mood, loss of pleasure, sleep disturbance and suicidal thinking.

2. The specificity of irradiation. X-irradiation stops the division of new neurons, but it may also affect other dividing cells, blood vessels and inflammation in the irradiated area. The authors took steps to limit this, yet any ablation leaves open the possibility that the behavior changed for reasons other than the loss of new neurons.

3. The knockout strain. Mice lacking the serotonin 1A receptor lack it throughout development and in every region. Their failure to respond to fluoxetine shows that the receptor matters, but it does not isolate neurogenesis as the reason.

4. The healthy animals. The mice were not first made depression-like. Whether neurogenesis is needed to reverse an induced depressive state was a separate question.

Later work from the same laboratory addressed the fourth point. In mice made anxious and depression-like by chronic corticosterone, fluoxetine reversed the behavioral changes and restored neurogenesis, but when neurogenesis was abolished by irradiation, fluoxetine's effect was blocked in some behavioral tests and not in others (David et al., 2009). The authors' own follow-up found that antidepressants act through both neurogenesis-dependent and neurogenesis-independent routes, which is already a smaller claim than the one that entered popular articles.

From Mouse to Human

The popular version of the claim also assumes that adult humans make new hippocampal neurons in meaningful numbers. That assumption became contested in 2018. Sorrells and colleagues examined human hippocampal tissue from fetal life to old age and found that young neurons declined sharply in the first year of life, were rare by adolescence and were not detected in adults (Sorrells et al., 2018). In the same year, Boldrini and colleagues studied whole hippocampi from healthy people aged [14] to [79] and reported thousands of immature neurons and preserved neurogenesis across ages, though with less angiogenesis and a smaller pool of quiescent progenitors in older people (Boldrini et al., 2018).

The two studies used different tissue sources, markers and methods, and the disagreement has not been settled. For the present critique, the point is that the human premise of the popular claim, that antidepressants work in people by increasing neurogenesis, rests on a process whose size in the adult human brain is still debated.

A Test the Study Could Not Run

The strongest test of the claim would be to block neurogenesis in depressed people and see whether antidepressants stop working. That experiment is impossible for obvious ethical reasons, which is why mice carry so much of the argument. The next best human evidence would be imaging that tracks neurogenesis in living patients as they respond or fail to respond to treatment, but no current scan can count new neurons directly. Postmortem studies can compare treated and untreated brains, yet they cannot show what the neurons were doing when the person was alive or whether their number changed the person's mood. Until one of these gaps is closed, any statement about neurogenesis in treated patients is an inference across species, not an observation. The critique therefore treats the popular claim as a hypothesis with good animal support, not as an explanation clinicians can give as fact.

Does the Popular Conclusion Stay Within the Evidence?

The authors wrote that antidepressant effects may be mediated by neurogenesis, a cautious claim about mice. The popular version became "antidepressants work by growing new neurons," a confident claim about people. The critique finds four gaps between them: from necessity in mice to sufficiency in anyone; from anxiety-related behavior to depression; from a single mechanism to one of several, as the laboratory's own later work showed; and from rodent to human brain, where adult neurogenesis is disputed.

Implications for a Psychiatric Nurse Practitioner

When a patient asks how their antidepressant works, a clinician should resist giving a single mechanism as settled. An honest answer is that antidepressants change several brain systems over weeks, including the connections and growth of nerve cells, and that researchers are still working out which changes matter most. The Santarelli study is best taught as an example of good experimental design whose conclusion was stretched as it traveled, and as a reminder to read the original methods before repeating a claim.

References

Boldrini, M., Fulmore, C. A., Tartt, A. N., Simeon, L. R., Pavlova, I., Poposka, V., Rosoklija, G. B., Stankov, A., Arango, V., Dwork, A. J., Hen, R., & Mann, J. J. (2018). Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell, 22(4), 589-599. https://doi.org/10.1016/j.stem.2018.03.015

David, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D. A., Guiard, B. P., Guilloux, J.-P., Artymyshyn, R. P., Gardier, A. M., Gerald, C., Antonijevic, I. A., Leonardo, E. D., & Hen, R. (2009). Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron, 62(4), 479-493. https://doi.org/10.1016/j.neuron.2009.04.017

Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C., & Hen, R. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301(5634), 805-809. https://doi.org/10.1126/science.1083328

Sorrells, S. F., Paredes, M. F., Cebrian-Silla, A., Sandoval, K., Qi, D., Kelley, K. W., James, D., Mayer, S., Chang, J., Auguste, K. I., Chang, E. F., Gutierrez, A. J., Kriegstein, A. R., Mathern, G. W., Oldham, M. C., Huang, E. J., Garcia-Verdugo, J. M., Yang, Z., & Alvarez-Buylla, A. (2018). Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature, 555(7696), 377-381. https://doi.org/10.1038/nature25975